marketcaparena
Search

    CNMD

    CONMED Corp

    Company overview

    Market capitalization
    $1.39B
    Employees
    3,900
    Latest publication
    2026-09-29
    About CONMED Corp

    CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue317,046,000USD373,474,000USD338,579,000USD343,038,000USD319,405,000USD345,944,000USD316,701,000USD332,097,000USD
    Cost Of Revenue133,599,000USD160,148,000USD180,619,000USD162,518,000USD151,518,000USD147,600,000USD137,706,000USD148,368,000USD
    Gross Profit183,447,000USD213,326,000USD157,960,000USD180,520,000USD167,887,000USD198,344,000USD178,995,000USD183,729,000USD
    Research Development16,333,000USD14,899,000USD13,901,000USD14,138,000USD12,947,000USD13,176,000USD13,558,000USD14,098,000USD
    Selling General Administrative141,699,000USD166,762,000USD122,083,000USD120,828,000USD148,847,000USD132,669,000USD99,730,000USD122,524,000USD
    Total Operating Expenses158,032,000USD146,454,000USD138,561,000USD138,801,000USD156,408,000USD145,845,000USD113,288,000USD136,622,000USD
    Operating Income25,415,000USD66,872,000USD19,399,000USD41,719,000USD11,479,000USD52,499,000USD65,707,000USD47,107,000USD
    Interest Expense7,060,000USD7,370,000USD7,606,000USD7,824,000USD8,286,000USD8,857,000USD9,252,000USD9,593,000USD
    Net Interest Income-7,060,000USD-7,371,000USD-7,606,000USD-7,824,000USD-8,286,000USD-8,857,000USD-9,252,000USD-9,593,000USD
    Income Before Tax18,355,000USD29,253,000USD4,273,000USD29,919,000USD7,672,000USD43,642,000USD56,455,000USD37,514,000USD
    Income Tax Expense4,527,000USD12,514,000USD1,414,000USD8,498,000USD1,636,000USD9,887,000USD7,471,000USD7,538,000USD
    Tax Provision4,527,000USD12,514,000USD1,414,000USD8,498,000USD1,636,000USD9,887,000USD7,471,000USD7,538,000USD
    Net Income13,828,000USD16,739,000USD2,859,000USD21,421,000USD6,036,000USD33,755,000USD48,984,000USD29,976,000USD
    Net Income From Continuing Ops13,828,000USD16,739,000USD2,859,000USD21,421,000USD6,036,000USD33,755,000USD48,984,000USD29,976,000USD
    Ebit25,415,000USD36,623,000USD11,879,000USD37,743,000USD15,958,000USD52,499,000USD65,707,000USD47,107,000USD
    Ebitda38,289,000USD55,473,000USD24,955,000USD50,909,000USD28,893,000USD70,505,000USD83,681,000USD64,946,000USD
    Depreciation And Amortization12,874,000USD18,850,000USD13,076,000USD13,166,000USD12,935,000USD18,006,000USD17,974,000USD17,839,000USD
    Reconciled Depreciation18,837,000USD18,850,000USD18,607,000USD18,571,000USD18,253,000USD18,006,000USD17,974,000USD17,839,000USD
    Total Other Income Expense Net-7,060,000USD-37,619,000USD-15,126,000USD-11,800,000USD-3,807,000USD-8,857,000USD-9,252,000USD-9,593,000USD
    Unclassified Operating Expenses—-35,207,000USD2,577,000USD3,835,000USD-5,386,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue1,374,495,000USD1,307,015,000USD1,244,744,000USD1,045,472,000USD1,010,635,000USD862,459,000USD955,097,000USD859,634,000USD
    Cost Of Revenue649,120,000USD573,983,000USD568,499,000USD474,227,000USD442,599,000USD402,159,000USD430,382,000USD390,524,000USD
    Gross Profit725,375,000USD733,032,000USD676,245,000USD571,245,000USD568,036,000USD460,300,000USD524,715,000USD469,110,000USD
    Research Development55,884,000USD54,426,000USD52,602,000USD47,152,000USD43,565,000USD40,473,000USD45,460,000USD42,188,000USD
    Selling General Administrative591,969,000USD453,990,000USD505,817,000USD454,039,000USD414,754,000USD373,817,000USD400,141,000USD355,617,000USD
    Unclassified Operating Expenses-63,609,000USD24,290,000USD——————
    Total Operating Expenses584,244,000USD532,706,000USD555,642,000USD501,191,000USD458,319,000USD414,290,000USD445,601,000USD397,805,000USD
    Operating Income141,131,000USD200,326,000USD120,603,000USD70,054,000USD109,717,000USD46,010,000USD79,114,000USD71,305,000USD
    Interest Expense31,087,000USD37,297,000USD39,775,000USD28,905,000USD35,485,000USD44,052,000USD42,701,000USD20,652,000USD
    Net Interest Income-31,087,000USD-37,297,000USD-39,714,000USD-28,905,000USD-35,485,000USD-44,052,000USD-42,701,000USD-20,652,000USD
    Income Before Tax71,117,000USD163,029,000USD80,828,000USD-70,862,000USD73,105,000USD1,603,000USD31,225,000USD50,653,000USD
    Income Tax Expense24,062,000USD30,606,000USD16,369,000USD9,720,000USD10,563,000USD-7,914,000USD2,605,000USD9,799,000USD
    Tax Provision24,062,000USD30,606,000USD-28,365,000USD9,720,000USD10,563,000USD-7,914,000USD2,605,000USD9,799,000USD
    Net Income47,055,000USD132,423,000USD64,459,000USD-80,582,000USD62,542,000USD9,517,000USD28,620,000USD40,854,000USD
    Net Income From Continuing Ops47,055,000USD132,423,000USD57,972,000USD-80,582,000USD62,542,000USD9,517,000USD28,620,000USD40,854,000USD
    Ebit102,204,000USD200,326,000USD120,603,000USD-41,957,000USD108,590,000USD45,655,000USD73,926,000USD71,305,000USD
    Ebitda154,547,000USD272,183,000USD192,477,000USD7,798,000USD179,333,000USD118,280,000USD146,249,000USD133,108,000USD
    Depreciation And Amortization52,343,000USD71,857,000USD71,874,000USD49,755,000USD70,743,000USD72,625,000USD72,323,000USD61,803,000USD
    Reconciled Depreciation74,281,000USD71,857,000USD71,609,000USD69,519,000USD70,743,000USD72,625,000USD72,323,000USD61,803,000USD
    Total Other Income Expense Net-70,014,000USD-37,297,000USD-39,775,000USD-140,916,000USD-36,612,000USD-44,407,000USD-47,889,000USD-20,652,000USD
    Non Operating Income Net Other———-112,011,000USD-1,127,000USD-355,000USD-5,188,000USD—
    Net Income Applicable To Common Shares———-80,582,000USD62,542,000USD9,517,000USD28,620,000USD40,854,000USD
    Interest Income——————42,701,000USD20,652,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets2,300,306,000USD2,314,942,000USD2,325,749,000USD2,322,488,000USD2,328,458,000USD2,297,683,000USD2,306,247,000USD2,315,744,000USD
    Cash And Equivalents37,328,000USD———————
    Total Current Assets675,665,000USD670,591,000USD672,860,000USD662,158,000USD657,780,000USD639,000,000USD640,007,000USD640,999,000USD
    Other Current Assets38,388,000USD40,794,000USD28,669,000USD33,931,000USD27,445,000USD27,695,000USD31,096,000USD28,753,000USD
    Other Non Current Assets153,179,000USD———————
    Total Liabilities1,258,916,000USD———————
    Total Current Liabilities455,399,000USD292,716,000USD315,041,000USD314,699,000USD294,838,000USD283,148,000USD278,130,000USD282,311,000USD
    Other Current Liabilities106,766,000USD———————
    Other Non Current Liabilities61,884,000USD———————
    Total Stockholder Equity1,041,390,000USD1,017,673,000USD1,033,097,000USD1,008,263,000USD1,002,870,000USD977,636,000USD962,681,000USD932,896,000USD
    Total Equity Including Noncontrolling Interest1,041,390,000USD———————
    Long Term Debt657,050,000USD860,157,000USD834,230,000USD853,007,000USD881,111,000USD891,443,000USD905,066,000USD940,094,000USD
    Net Receivables239,770,000USD228,661,000USD247,830,000USD224,943,000USD234,148,000USD221,138,000USD237,733,000USD231,229,000USD
    Inventory360,179,000USD366,106,000USD355,544,000USD364,355,000USD362,252,000USD354,682,000USD346,719,000USD342,550,000USD
    Property Plant Equipment Net110,144,000USD111,964,000USD113,331,000USD112,036,000USD116,863,000USD116,059,000USD115,793,000USD117,415,000USD
    Goodwill796,902,000USD———————
    Intangible Assets564,416,000USD573,804,000USD582,051,000USD593,107,000USD601,817,000USD609,833,000USD617,663,000USD625,569,000USD
    Accounts Payable101,017,000USD105,416,000USD93,648,000USD107,087,000USD101,054,000USD95,731,000USD102,248,000USD104,571,000USD
    Common Stock313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD
    Retained Earnings625,665,000USD602,594,000USD588,766,000USD572,027,000USD575,359,000USD560,127,000USD560,277,000USD532,701,000USD
    Accumulated Other Comprehensive Income-43,372,000USD-44,687,000USD-46,295,000USD-49,232,000USD-52,978,000USD-57,392,000USD-58,857,000USD-54,717,000USD
    Total Liab—1,297,269,000USD1,292,652,000USD1,314,225,000USD1,325,588,000USD1,320,047,000USD1,343,566,000USD1,382,848,000USD
    Other Current Liab—186,589,000USD220,681,000USD206,866,000USD193,070,000USD186,703,000USD175,167,000USD177,023,000USD
    Capital Stock—313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD
    Good Will—806,858,000USD807,011,000USD806,916,000USD806,926,000USD805,697,000USD805,358,000USD806,871,000USD
    Cash—35,030,000USD40,817,000USD38,929,000USD33,935,000USD35,485,000USD24,459,000USD38,467,000USD
    Cash And Short Term Investments—35,030,000USD40,817,000USD38,929,000USD33,935,000USD35,485,000USD24,459,000USD38,467,000USD
    Net Debt—825,838,000USD794,125,000USD814,824,000USD847,890,000USD856,672,000USD881,322,000USD902,344,000USD
    Short Term Debt—711,000USD712,000USD746,000USD714,000USD714,000USD715,000USD717,000USD
    Short Long Term Debt—711,000USD712,000USD746,000USD714,000USD714,000USD715,000USD717,000USD
    Short Long Term Debt Total—860,868,000USD834,942,000USD853,753,000USD881,825,000USD892,157,000USD905,781,000USD940,811,000USD
    Common Stock Shares Outstanding—30,621,000shares31,030,000shares31,050,000shares31,054,000shares31,151,000shares31,112,000shares31,112,000shares
    Non Current Assets Total—1,644,351,000USD1,652,889,000USD1,660,330,000USD1,670,678,000USD1,658,683,000USD1,666,240,000USD1,674,745,000USD
    Non Current Liabilities Total—1,004,553,000USD977,611,000USD999,526,000USD1,030,750,000USD1,036,899,000USD1,065,436,000USD1,100,537,000USD
    Non Current Liabilities Other—63,020,000USD63,851,000USD71,662,000USD79,821,000USD75,504,000USD86,294,000USD94,623,000USD
    Non Currrent Assets Other—151,069,000USD137,187,000USD148,271,000USD145,072,000USD127,094,000USD116,357,000USD59,070,000USD
    Net Working Capital—377,875,000USD357,819,000USD347,459,000USD362,942,000USD355,852,000USD361,877,000USD358,688,000USD
    Unclassified Non Current Liabilities—81,376,000USD79,530,000USD74,857,000USD69,818,000USD69,952,000USD74,076,000USD65,820,000USD
    Unclassified Equity—459,140,000USD490,000,000USD484,842,000USD479,863,000USD474,275,000USD460,635,000USD454,286,000USD
    Property Plant Equipment Gross——429,960,000USD———421,212,000USD—
    Unclassified Non Current Assets———————65,820,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets2,325,749,000USD2,306,247,000USD2,300,021,000USD2,297,592,000USD1,766,017,000USD1,751,673,000USD1,775,095,000USD1,369,138,000USD
    Intangible Assets582,051,000USD617,663,000USD649,484,000USD681,799,000USD471,049,000USD501,537,000USD532,800,000USD413,193,000USD
    Other Current Assets28,669,000USD31,096,000USD30,750,000USD28,619,000USD23,750,000USD17,278,000USD17,794,000USD20,691,000USD
    Total Liab1,292,652,000USD1,343,566,000USD1,465,799,000USD1,552,047,000USD980,582,000USD1,042,635,000USD1,064,628,000USD706,868,000USD
    Total Stockholder Equity1,033,097,000USD962,681,000USD834,222,000USD745,545,000USD785,435,000USD709,038,000USD710,467,000USD662,270,000USD
    Other Current Liab220,681,000USD175,167,000USD214,288,000USD153,413,000USD126,200,000USD110,810,000USD111,255,000USD89,110,000USD
    Common Stock313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD
    Capital Stock313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD313,000USD
    Retained Earnings588,766,000USD560,277,000USD452,531,000USD412,631,000USD496,605,000USD457,417,000USD470,844,000USD464,851,000USD
    Good Will807,011,000USD805,358,000USD806,844,000USD815,429,000USD617,528,000USD618,440,000USD618,042,000USD400,440,000USD
    Cash40,817,000USD24,459,000USD24,296,000USD28,942,000USD20,847,000USD27,356,000USD25,856,000USD17,511,000USD
    Cash And Short Term Investments40,817,000USD24,459,000USD24,296,000USD28,942,000USD20,847,000USD27,356,000USD25,856,000USD17,511,000USD
    Total Current Assets672,860,000USD640,007,000USD615,649,000USD581,226,000USD460,123,000USD416,654,000USD397,363,000USD374,351,000USD
    Total Current Liabilities315,041,000USD278,130,000USD310,729,000USD296,552,000USD196,646,000USD190,201,000USD188,087,000USD160,944,000USD
    Net Debt794,125,000USD881,322,000USD966,958,000USD1,025,880,000USD663,809,000USD749,092,000USD767,315,000USD439,389,000USD
    Short Term Debt712,000USD715,000USD8,217,000USD69,746,000USD12,249,000USD26,081,000USD20,864,000USD18,336,000USD
    Short Long Term Debt712,000USD715,000USD708,000USD69,746,000USD12,249,000USD18,218,000USD13,596,000USD18,336,000USD
    Short Long Term Debt Total834,942,000USD905,781,000USD991,254,000USD1,054,822,000USD684,656,000USD776,448,000USD793,171,000USD456,900,000USD
    Long Term Debt834,230,000USD905,066,000USD973,140,000USD985,076,000USD672,407,000USD734,831,000USD755,211,000USD438,564,000USD
    Net Receivables247,830,000USD237,733,000USD242,279,000USD191,345,000USD183,882,000USD177,152,000USD189,097,000USD181,550,000USD
    Inventory355,544,000USD346,719,000USD318,324,000USD332,320,000USD231,644,000USD194,868,000USD164,616,000USD154,599,000USD
    Accounts Payable93,648,000USD102,248,000USD88,224,000USD73,393,000USD58,197,000USD53,310,000USD55,968,000USD53,498,000USD
    Property Plant Equipment Net113,331,000USD115,793,000USD120,722,000USD115,611,000USD108,863,000USD111,407,000USD118,883,000USD113,245,000USD
    Property Plant Equipment Gross429,960,000USD421,212,000USD412,884,000USD393,147,000USD372,624,000USD111,407,000USD118,883,000USD113,245,000USD
    Accumulated Other Comprehensive Income-46,295,000USD-58,857,000USD-50,170,000USD-57,858,000USD-54,203,000USD-63,681,000USD-59,277,000USD-55,737,000USD
    Common Stock Shares Outstanding31,149,000shares31,112,000shares31,548,000shares30,040,000shares32,216,000shares29,464,000shares29,495,000shares28,890,000shares
    Non Current Assets Total1,652,889,000USD1,666,240,000USD1,684,372,000USD1,716,366,000USD1,305,894,000USD1,335,019,000USD1,377,732,000USD994,787,000USD
    Non Current Liabilities Total977,611,000USD1,065,436,000USD1,155,070,000USD1,255,495,000USD783,936,000USD852,434,000USD876,541,000USD545,924,000USD
    Non Current Liabilities Other63,851,000USD86,294,000USD121,028,000USD203,694,000USD42,992,000USD59,338,000USD46,842,000USD26,299,000USD
    Non Currrent Assets Other137,187,000USD116,357,000USD96,111,000USD93,877,000USD98,797,000USD96,793,000USD102,348,000USD62,747,000USD
    Net Working Capital357,819,000USD361,877,000USD304,920,000USD284,674,000USD263,477,000USD226,453,000USD209,276,000USD213,407,000USD
    Unclassified Non Current Liabilities79,530,000USD74,076,000USD60,902,000USD-258,660,000USD-98,803,000USD-102,067,000USD-104,234,000USD-107,360,000USD
    Unclassified Equity490,000,000USD460,635,000USD431,235,000USD412,922,000USD396,458,000USD382,315,000USD379,011,000USD341,425,000USD
    Current Deferred Revenue——-8,217,000USD9,650,000USD60,488,000USD50,171,000USD53,690,000USD42,924,000USD
    Deferred Long Term Liab———66,725,000USD68,537,000USD57,875,000USD74,488,000USD81,061,000USD
    Other Liab———258,660,000USD98,803,000USD102,457,000USD104,234,000USD107,360,000USD
    Other Assets———85,817,000USD89,029,000USD103,635,000USD84,908,000USD67,909,000USD
    Treasury Stock———-22,776,000USD-54,051,000USD-67,639,000USD-80,737,000USD-88,895,000USD
    Net Tangible Assets———-751,683,000USD-340,829,000USD-410,939,000USD-440,375,000USD-151,363,000USD
    Unclassified Non Current Assets———-76,167,000USD-79,372,000USD-96,793,000USD-79,249,000USD-62,747,000USD
    Unclassified Current Liabilities———-79,396,000USD-72,737,000USD-68,389,000USD-67,286,000USD-61,260,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income13,828,000USD16,739,000USD2,859,000USD21,421,000USD6,036,000USD33,754,000USD48,983,000USD29,976,000USD
    Depreciation4,174,000USD18,850,000USD18,607,000USD18,571,000USD18,253,000USD18,006,000USD12,995,000USD17,839,000USD
    Stock Based Compensation5,502,000USD4,971,000USD4,586,000USD4,903,000USD13,863,000USD6,222,000USD6,122,000USD6,974,000USD
    Other Non Cash Items12,745,000USD20,986,000USD2,617,000USD-48,000USD5,405,000USD2,664,000USD-36,466,000USD-7,268,000USD
    Change To Account Receivables18,606,000USD-22,671,000USD9,163,000USD-7,837,000USD18,984,000USD-12,400,000USD10,775,000USD914,000USD
    Change To Inventory-12,269,000USD8,509,000USD-2,216,000USD-5,551,000USD-7,475,000USD-7,197,000USD-18,641,000USD-746,000USD
    Change In Working Capital-24,312,000USD-16,023,000USD21,331,000USD-17,397,000USD636,000USD-23,884,000USD17,049,000USD-5,456,000USD
    Total Cash From Operating Activities13,472,000USD46,335,000USD53,686,000USD29,134,000USD41,534,000USD43,338,000USD51,203,000USD43,306,000USD
    Capital Expenditures-2,892,000USD-5,111,000USD-5,187,000USD-5,729,000USD-3,779,000USD-4,040,000USD-3,419,000USD-3,590,000USD
    Free Cash Flow10,580,000USD41,224,000USD48,499,000USD23,405,000USD37,755,000USD39,298,000USD47,784,000USD39,716,000USD
    Total Cashflows From Investing Activities4,108,000USD-7,111,000USD-5,187,000USD-5,729,000USD-2,929,000USD-4,040,000USD-3,419,000USD-3,590,000USD
    Net Borrowings25,000,000USD-20,000,000USD-29,000,000USD-10,999,000USD-14,588,000USD-36,000,000USD-26,000,000USD—
    Total Cash From Financing Activities-22,553,000USD-37,370,000USD-43,525,000USD-26,527,000USD-28,398,000USD-51,070,000USD-38,831,000USD-44,085,000USD
    Dividends Paid0USD-6,191,000USD-6,189,000USD-6,186,000USD-6,180,000USD-6,177,000USD-6,163,000USD-6,158,000USD
    Sale Purchase Of Stock-37,017,000USD———0USD———
    Change In Cash-5,787,000USD1,888,000USD4,994,000USD-1,550,000USD11,026,000USD-14,008,000USD9,598,000USD-4,986,000USD
    Begin Period Cash Flow40,817,000USD38,929,000USD33,935,000USD35,485,000USD24,459,000USD38,467,000USD28,869,000USD33,855,000USD
    End Period Cash Flow35,030,000USD40,817,000USD38,929,000USD33,935,000USD35,485,000USD24,459,000USD38,467,000USD28,869,000USD
    Other Cashflows From Investing Activities7,000,000USD-2,000,000USD——850,000USD———
    Other Cashflows From Financing Activities-10,536,000USD-11,179,000USD-8,336,000USD-9,342,000USD-7,630,000USD-8,590,000USD-6,668,000USD-11,927,000USD
    Unclassified Operating Cash Flow1,535,000USD—3,686,000USD1,684,000USD-2,659,000USD6,576,000USD2,520,000USD1,241,000USD
    Investments——-5,187,000USD-5,729,000USD-2,929,000USD-4,040,000USD-3,419,000USD-3,590,000USD
    Unclassified Investing Cash Flow——5,187,000USD5,729,000USD2,929,000USD4,040,000USD3,419,000USD3,590,000USD
    Unclassified Financing Cash Flow———————-26,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income47,055,000USD132,423,000USD64,459,000USD-80,582,000USD62,542,000USD9,517,000USD28,620,000USD40,854,000USD
    Depreciation74,281,000USD51,305,000USD51,400,000USD69,519,000USD70,743,000USD72,625,000USD72,323,000USD61,803,000USD
    Stock Based Compensation28,323,000USD25,558,000USD24,257,000USD21,729,000USD16,335,000USD13,111,000USD11,779,000USD10,037,000USD
    Other Non Cash Items28,960,000USD-14,796,000USD24,111,000USD119,439,000USD14,842,000USD13,415,000USD12,368,000USD4,212,000USD
    Change To Account Receivables-2,361,000USD-1,619,000USD-47,068,000USD-5,203,000USD-9,159,000USD13,920,000USD-13,943,000USD-17,460,000USD
    Change To Inventory-6,733,000USD-31,633,000USD14,071,000USD-78,564,000USD-37,806,000USD-30,397,000USD-117,000USD-15,037,000USD
    Change In Working Capital-11,453,000USD-39,724,000USD-39,579,000USD-90,698,000USD-55,697,000USD-29,903,000USD-23,647,000USD-44,268,000USD
    Total Cash From Operating Activities170,689,000USD166,968,000USD125,348,000USD33,365,000USD111,770,000USD64,531,000USD95,133,000USD74,701,000USD
    Capital Expenditures-19,806,000USD-13,084,000USD-19,032,000USD-21,785,000USD-14,866,000USD-13,013,000USD-20,066,000USD-16,507,000USD
    Free Cash Flow150,883,000USD153,884,000USD106,316,000USD11,580,000USD96,904,000USD51,518,000USD75,067,000USD58,194,000USD
    Total Cashflows From Investing Activities-20,956,000USD-13,084,000USD-20,032,000USD-249,529,000USD-14,866,000USD-13,638,000USD-387,662,000USD-16,507,000USD
    Net Borrowings-74,587,000USD-72,000,000USD-88,000,000USD340,189,000USD-83,243,000USD-29,403,000USD346,642,000USD-30,612,000USD
    Total Cash From Financing Activities-135,820,000USD-151,000,000USD-110,432,000USD225,000,000USD-101,548,000USD-52,059,000USD300,881,000USD-72,265,000USD
    Dividends Paid-24,746,000USD-24,651,000USD-24,502,000USD-23,960,000USD-23,256,000USD-22,818,000USD-22,600,000USD-22,443,000USD
    Change In Cash16,358,000USD163,000USD-4,646,000USD8,095,000USD-6,509,000USD1,500,000USD8,345,000USD-15,111,000USD
    Begin Period Cash Flow24,459,000USD24,296,000USD28,942,000USD20,847,000USD27,356,000USD25,856,000USD17,511,000USD32,622,000USD
    End Period Cash Flow40,817,000USD24,459,000USD24,296,000USD28,942,000USD20,847,000USD27,356,000USD25,856,000USD17,511,000USD
    Other Cashflows From Investing Activities-1,150,000USD—-1,000,000USD-227,744,000USD—-625,000USD-367,596,000USD—
    Other Cashflows From Financing Activities-36,487,000USD-54,349,000USD2,070,000USD1,146,941,000USD382,115,000USD196,009,000USD962,629,000USD-20,123,000USD
    Unclassified Operating Cash Flow3,523,000USD12,202,000USD—-6,042,000USD3,005,000USD-14,234,000USD-6,310,000USD2,063,000USD
    Investments—-13,084,000USD-21,495,000USD-249,529,000USD-14,866,000USD-13,638,000USD-387,662,000USD-16,507,000USD
    Unclassified Investing Cash Flow—13,084,000USD21,495,000USD249,529,000USD14,866,000USD13,638,000USD387,662,000USD16,507,000USD
    Change To Liabilities———10,804,000USD15,273,000USD-2,977,000USD38,000USD12,445,000USD
    Sale Purchase Of Stock———2,466,000USD——30,567,000USD—
    Cash And Cash Equivalents Changes———8,836,000USD-6,509,000USD1,500,000USD8,345,000USD-15,111,000USD
    Unclassified Financing Cash Flow———-1,240,636,000USD-377,164,000USD-195,847,000USD-1,016,357,000USD—
    Exchange Rate Changes————-1,865,000USD2,666,000USD-7,000USD-1,040,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyAmericasexcludingthe United States34,799,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyAsia Pacific57,157,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyEMEA76,147,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States175,385,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductGeneral Surgery191,173,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductOrthopedic Surgery152,315,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyAmericasexcludingthe United States32,896,000USD0000816956-26-000053
    Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific41,958,000USD0000816956-26-000053
    Q1 2026Quarterly · 2026-03-31GeographyEMEA69,137,000USD0000816956-26-000053
    Q1 2026Quarterly · 2026-03-31GeographyUnited States173,055,000USD0000816956-26-000053
    Q1 2026Quarterly · 2026-03-31ProductGeneral Surgery169,383,000USD0000816956-26-000053
    Q1 2026Quarterly · 2026-03-31ProductOrthopedic Surgery147,663,000USD0000816956-26-000053
    Q4 2025Quarterly · 2025-12-31GeographyAmericasexcludingthe United States33,339,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyAsia Pacific59,103,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyEMEA74,520,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States206,235,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductGeneral Surgery215,816,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductOrthopedic Surgery157,381,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyAmericasexcludingthe United States126,760,000USD0000816956-26-000009
    FY 2025Yearly · 2025-12-31GeographyAsia Pacific208,722,000USD0000816956-26-000009
    FY 2025Yearly · 2025-12-31GeographyEMEA264,654,000USD0000816956-26-000009
    FY 2025Yearly · 2025-12-31GeographyUnited States774,588,000USD0000816956-26-000009
    FY 2025Yearly · 2025-12-31ProductGeneral Surgery800,126,000USD0000816956-26-000009
    FY 2025Yearly · 2025-12-31ProductOrthopedic Surgery574,598,000USD0000816956-26-000009
    Q3 2025Quarterly · 2025-09-30GeographyAmericasexcludingthe United States31,440,000USD0000816956-25-000056
    Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific53,826,000USD0000816956-25-000056
    Q3 2025Quarterly · 2025-09-30GeographyEMEA58,681,000USD0000816956-25-000056
    Q3 2025Quarterly · 2025-09-30GeographyUnited States193,979,000USD0000816956-25-000056
    Q3 2025Quarterly · 2025-09-30ProductGeneral Surgery199,733,000USD0000816956-25-000056
    Q3 2025Quarterly · 2025-09-30ProductOrthopedic Surgery138,193,000USD0000816956-25-000056
    Q2 2025Quarterly · 2025-06-30GeographyAmericasexcludingthe United States31,875,000USD0000816956-25-000028
    Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific52,081,000USD0000816956-25-000028
    Q2 2025Quarterly · 2025-06-30GeographyEMEA67,777,000USD0000816956-25-000028
    Q2 2025Quarterly · 2025-06-30GeographyUnited States190,612,000USD0000816956-25-000028
    Q2 2025Quarterly · 2025-06-30ProductGeneral Surgery201,611,000USD0000816956-25-000028
    Q2 2025Quarterly · 2025-06-30ProductOrthopedic Surgery140,734,000USD0000816956-25-000028
    Q1 2025Quarterly · 2025-03-31GeographyAmericasexcludingthe United States30,106,000USD0000816956-26-000053
    Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific43,712,000USD0000816956-26-000053
    Q1 2025Quarterly · 2025-03-31GeographyEMEA63,676,000USD0000816956-26-000053
    Q1 2025Quarterly · 2025-03-31GeographyUnited States183,762,000USD0000816956-26-000053
    Q1 2025Quarterly · 2025-03-31ProductGeneral Surgery182,966,000USD0000816956-26-000053
    Q1 2025Quarterly · 2025-03-31ProductOrthopedic Surgery138,290,000USD0000816956-26-000053
    Q4 2024Quarterly · 2024-12-31GeographyAmericasexcludingthe United States29,964,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyAsia Pacific49,683,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyEMEA62,997,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States203,300,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductGeneral Surgery206,942,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOrthopedic Surgery139,002,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAmericasexcludingthe United States121,043,000USD0000816956-26-000009
    FY 2024Yearly · 2024-12-31GeographyAsia Pacific194,684,000USD0000816956-26-000009
    FY 2024Yearly · 2024-12-31GeographyEMEA243,064,000USD0000816956-26-000009
    FY 2024Yearly · 2024-12-31GeographyUnited States748,224,000USD0000816956-26-000009
    FY 2024Yearly · 2024-12-31ProductGeneral Surgery763,027,000USD0000816956-26-000009
    FY 2024Yearly · 2024-12-31ProductOrthopedic Surgery543,988,000USD0000816956-26-000009
    Q3 2024Quarterly · 2024-09-30GeographyAmericasexcludingthe United States28,819,000USD0000816956-25-000056
    Q3 2024Quarterly · 2024-09-30GeographyAsia Pacific49,209,000USD0000816956-25-000056
    Q3 2024Quarterly · 2024-09-30GeographyEMEA55,522,000USD0000816956-25-000056
    Q3 2024Quarterly · 2024-09-30GeographyUnited States183,151,000USD0000816956-25-000056
    Q3 2024Quarterly · 2024-09-30ProductGeneral Surgery186,164,000USD0000816956-25-000056
    Q3 2024Quarterly · 2024-09-30ProductOrthopedic Surgery130,537,000USD0000816956-25-000056
    FY 2023Yearly · 2023-12-31GeographyAmericasexcludingthe United States120,930,000USD0000816956-26-000009
    FY 2023Yearly · 2023-12-31GeographyAsia Pacific197,401,000USD0000816956-26-000009
    FY 2023Yearly · 2023-12-31GeographyEMEA226,253,000USD0000816956-26-000009
    FY 2023Yearly · 2023-12-31GeographyUnited States700,160,000USD0000816956-26-000009
    FY 2023Yearly · 2023-12-31ProductGeneral Surgery711,586,000USD0000816956-26-000009
    FY 2023Yearly · 2023-12-31ProductOrthopedic Surgery533,158,000USD0000816956-26-000009
    FY 2022Yearly · 2022-12-31GeographyAmericasexcludingthe United States106,105,000USD0000816956-25-000004
    FY 2022Yearly · 2022-12-31GeographyAsia Pacific162,477,000USD0000816956-25-000004
    FY 2022Yearly · 2022-12-31GeographyEMEA197,937,000USD0000816956-25-000004
    FY 2022Yearly · 2022-12-31GeographyUnited States578,953,000USD0000816956-25-000004
    FY 2022Yearly · 2022-12-31ProductGeneral Surgery583,944,000USD0000816956-25-000004
    FY 2022Yearly · 2022-12-31ProductOrthopedic Surgery461,528,000USD0000816956-25-000004
    FY 2021Yearly · 2021-12-31GeographyAmericasexcludingthe United States97,189,000USD0000816956-24-000003
    FY 2021Yearly · 2021-12-31GeographyAsia Pacific171,218,000USD0000816956-24-000003
    FY 2021Yearly · 2021-12-31GeographyEMEA189,695,000USD0000816956-24-000003
    FY 2021Yearly · 2021-12-31GeographyUnited States552,533,000USD0000816956-24-000003
    FY 2021Yearly · 2021-12-31ProductGeneral Surgery572,211,000USD0000816956-24-000003
    FY 2021Yearly · 2021-12-31ProductOrthopedic Surgery438,424,000USD0000816956-24-000003
    FY 2020Yearly · 2020-12-31GeographyAmericasexcludingthe United States78,714,000USD0000816956-23-000004
    FY 2020Yearly · 2020-12-31GeographyAsia Pacific140,597,000USD0000816956-23-000004
    FY 2020Yearly · 2020-12-31GeographyEMEA161,084,000USD0000816956-23-000004
    FY 2020Yearly · 2020-12-31GeographyUnited States482,064,000USD0000816956-23-000004
    FY 2020Yearly · 2020-12-31ProductGeneral Surgery487,754,000USD0000816956-23-000004
    FY 2020Yearly · 2020-12-31ProductOrthopedic Surgery374,705,000USD0000816956-23-000004
    FY 2019Yearly · 2019-12-31GeographyAmericasexcludingthe United States95,273,000USD0000816956-22-000004
    FY 2019Yearly · 2019-12-31GeographyAsia Pacific160,610,000USD0000816956-22-000004
    FY 2019Yearly · 2019-12-31GeographyEMEA182,549,000USD0000816956-22-000004
    FY 2019Yearly · 2019-12-31GeographyUnited States516,665,000USD0000816956-22-000004
    FY 2019Yearly · 2019-12-31ProductGeneral Surgery491,775,000USD0000816956-22-000004
    FY 2019Yearly · 2019-12-31ProductOrthopedic Surgery463,322,000USD0000816956-22-000004
    FY 2018Yearly · 2018-12-31GeographyAmericasexcludingthe United States97,528,000USD0000816956-21-000003
    FY 2018Yearly · 2018-12-31GeographyAsia Pacific146,895,000USD0000816956-21-000003
    FY 2018Yearly · 2018-12-31GeographyEMEA166,563,000USD0000816956-21-000003
    FY 2018Yearly · 2018-12-31GeographyUnited States448,648,000USD0000816956-21-000003
    FY 2018Yearly · 2018-12-31ProductGeneral Surgery412,906,000USD0000816956-21-000003
    FY 2018Yearly · 2018-12-31ProductOrthopedic Surgery446,728,000USD0000816956-21-000003
    Q4 2012Quarterly · 2012-12-31SegmentConmed Electrosurgery26,186,000USDLegacy provider
    Q4 2012Quarterly · 2012-12-31SegmentConmed Endoscopic Technologies13,396,000USDLegacy provider
    Q4 2012Quarterly · 2012-12-31SegmentConmed Endosurgery19,907,000USDLegacy provider
    Q4 2012Quarterly · 2012-12-31SegmentConmed Linvatec124,899,000USDLegacy provider

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.